Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Arcellx Inc (ACLX)

Arcellx Inc (ACLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Arcellx Inc 800 BRIDGE PARKWAY REDWOOD CITY CA 94065 USA

www.arcellx.com Employees: 130 P: 240-327-0630

Description:

Arcellx Inc. is a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc. is based in GAITHERSBURG, Md.

Key Statistics

Overview:

Market Capitalization, $K 4,084,826
Enterprise Value, $K 3,688,336
Shares Outstanding, K 54,075
Annual Sales, $ 110,320 K
Annual Net Income, $ -70,690 K
Last Quarter Sales, $ 26,030 K
Last Quarter Net Income, $ -25,870 K
EBIT, $ -69,420 K
EBITDA, $ -78,430 K
60-Month Beta 0.25
% of Insider Shareholders 6.24%
% of Institutional Shareholders 96.03%
Float, K 50,701
% Float 93.76%
Short Volume Ratio 0.84

Growth:

1-Year Return 49.11%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.48 on 11/07/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -0.71
EPS Growth vs. Prev Qtr 5.88%
EPS Growth vs. Prev Year 40.74%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ACLX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -8.28%
Return-on-Assets % -5.21%
Profit Margin % -64.08%
Debt/Equity 0.00
Price/Sales 36.87
Price/Cash Flow N/A
Price/Book 8.37
Book Value/Share 8.98
Interest Coverage -17.24
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar